While many who work in biotechnology or who are actively involved in life sciences in the world of academics are well aware of who Mark Ahn is, those who are outside of these communities in the public and private sector are not aware of the incredible contributions he has made to his field. Ahn is a highly accomplished biotechnology professional and academic, and his efforts in both the public and private sectors have been integral in transforming the industry. One of the many areas that he has achieved great success relates to the area of breast cancer research.
The Professional Life of Mark Ahn
Ahn is a highly educated biotechnology professional, and he also has more than two decades of professional work experience in high-level positions. His education includes degrees earned at schools like the University of South Australia, Chaminade University, Aspen Institute and other reputable schools. He also has worked in high level positions, including as president or CEO in some cases, at companies such as Bristol-Myers Squibb Company, Hana Biosciences, Genentech, Amgen and others. At each of these and other companies, his efforts have resulted in excellent research and innovations. Notably, at Galena Biopharma he played a role in research and clinical studies in the area of breast cancer research.
A Closer Look at Breast Cancer Research
Galena received a grant from the Department of Defense that providing a significant amount of funding for a clinical trial on breast cancer medication. The trial was in conjunction with NeuVax, and it focused on preventing the development of breast cancer in high risk patients. The funding provided for expanded research based on what was already taking place. In addition, he worked to secure a patent in the United States for the NeuVax breast cancer prevention medication that was being developed at the time. The studies and research are going well, and this is a medication that has the potential to save many lives going forward.
In a biotechnology firm that conducts research and that completes clinical studies, it generally is the work of a team of highly skilled and knowledgeable professionals who work collaboratively to bring about change. However, with a lead role in the company and with a proven desire to change the world through his efforts in all of his public and private roles over the course of his career, it is clear that Ahn will continue to be instrumental in the area of breast cancer research and other areas that he is currently focusing his efforts on.